First project started
Updated: Jul 23, 2019
10/28/2016
Giving patients a voice in drug development - PREFER is a five year project funded by the Innovative Medicines Initiative (IMI), to evaluate different preference elicitation methods and test them in a clinical setting. 16 pharmaceutical companies and 16 public partners form the project consortium with a total budget of 12 million €. For more info: www.imi-prefer.eu
